Time

Event

7:00 am

Registration

8:10 am –  Villard Ballroom

Welcome Remarks

• Sara Jane Demy, Founder & CEO, Demy-Colton

8:20 am – Villard Ballroom

“Big Think" Plenary Session 

Moving Health Forward: Exploring Where We Are and What Lies Ahead

9:30 am – Holmes I

Commercialization of Digital Health Care Products: The Need, The Obstacles, The Solutions

Moderator:

• Beth Rogozinski, CEO, Oncoustics

Panelists:

• Everett Crosland, Chief Commercial Officer, Cognito Therapeutics
• Additional Panelists TBA

9:30 am – Holmes II

Next-Generation Cancer Therapeutics

Moderator: 

• Jay Cambpell, Managing Director, Clinical Accelerator & Venture Fund, Cancer Research Institute 

Panelists:

• Jennifer Buell, CEO, MiNK Therapeutics

10:30 am – Holmes I

Neurotech: Non-Invasive Neuromodulation and Brain-Computer Interfaces

Panelists:

• Brent Vaughan, CEO, Cognito Therapeutics

10:30 am – Holmes II

Gene Editing Therapies

11:30 am – Holmes I

Leveraging AI and ML to Advance Discovery and Accelerate Drug Development

12:30 pm – Villard Ballroom

Fireside Chat: How Meaningful Data Will Transform Health

• Leroy Hood, MD, PhD, SVP & Chief Science Officer, Providence; Chief Strategy Officer, Co-Founder & Professor, Institute for Systems Biology (ISB)
• Scott Penberthy, Director, Applied AI, Office of the CTO, Google

2:00 pm – Holmes I

TechBio: Investment Fad or Here to Stay? 

3:00 pm – Holmes I

Impact of Wearable Sensors & Affective Computing 

Moderator: 

• Walter Greenleaf, PhD, Distinguished Visiting Scholar, Stanford University’s MediaX Program

3:00 pm – Holmes II

Women’s Health: Getting the Long Overdue Research Attention, Investment, & Innovation

Panelists:

• Chihiro Hosoya, Head of Venture Management & Business Development, Astellas Rx+Business Accelerator

4:00 pm – Holmes I

Diversity, Equity & Inclusion: Its Impact on Leadership of Therapeutic Developers 

Moderator: 

• Susanna Harris, PhD, Head, Communications, VIBE

Panelists:

• David Fortier, Managing Partner, Global Life Sciences Practice Leader, ZRG

4:00 pm – Holmes II

Chronic Disease: It is Ignored at our Peril

5:00 pm – Villard Ballroom

A “Big Think” Plenary

Funding Innovation in a New Environment: The New Normal (Or, is the New Normal the Same?)

Moderator: 

• Tim Opler, PhD, Partner & Co-Founder, Torreya

Panelists: 

• Rachelle Jacques, President & CEO, Akari Therapeutics
• Peter Rehnquist, Director, Corporate Development, XOMA
• Allan Shaw, CFO, Portage Biotech, Inc.